This company listing is no longer active
ImmuPharma Balance Sheet Health
Financial Health criteria checks 4/6
Key information
0.01%
Debt to equity ratio
UK£700.00
Debt
Interest coverage ratio | n/a |
Cash | UK£1.65m |
Equity | UK£4.41m |
Total liabilities | UK£1.58m |
Total assets | UK£6.00m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IMMP.F's short term assets (£3.3M) exceed its short term liabilities (£1.6M).
Long Term Liabilities: IMMP.F has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: IMMP.F has more cash than its total debt.
Reducing Debt: IMMP.F's debt to equity ratio has reduced from 6.5% to 0.02% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IMMP.F has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: IMMP.F has less than a year of cash runway if free cash flow continues to grow at historical rates of 7.6% each year.